Free Trial

REGENXBIO (RGNX) SEC Filings & 10K Form

REGENXBIO logo
$9.01 +0.90 (+11.10%)
Closing price 04:00 PM Eastern
Extended Trading
$9.02 +0.01 (+0.11%)
As of 04:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent REGENXBIO SEC Filings

DateFilerForm TypeView
08/18/2025
4:10 PM
REGENXBIO (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2025
6:30 AM
REGENXBIO (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2025
6:15 AM
REGENXBIO (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/15/2025
4:12 PM
BlackRock Portfolio Management LLC (Filed by)
REGENXBIO (Subject)
Form SCHEDULE 13G
07/03/2025
5:53 PM
REGENXBIO (Issuer)
Simpson Curran (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2025
11:15 PM
REGENXBIO (Filer)
Form EFFECT
06/25/2025
3:15 PM
REGENXBIO (Filer)
Form 424B3
06/13/2025
4:19 PM
REGENXBIO (Filer)
Form S-3
Registration statement under Securities Act of 1933  
06/03/2025
3:30 PM
REGENXBIO (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/03/2025
3:31 PM
Bennett Jean (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2025
3:31 PM
KARABELAS ARGERIS N (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2025
3:32 PM
Glucksmann Alexandra (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2025
3:32 PM
MIGAUSKY GEORGE V (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2025
3:29 PM
Mills Kenneth T. (Reporting)
REGENXBIO (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/24/2025
7:59 AM
BlackRock, Inc. (Filed by)
REGENXBIO (Subject)
Form SCHEDULE 13G/A
04/14/2025
11:15 PM
REGENXBIO (Filer)
Form EFFECT
04/04/2025
4:16 PM
Danos Olivier (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2025
4:17 PM
PAKOLA STEVE (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2025
4:17 PM
Christmas Patrick J. (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/31/2025
4:05 PM
Mills Kenneth T. (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2025
6:02 PM
Malzahn Craig (Reporting)
REGENXBIO (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/13/2025
3:49 PM
REGENXBIO (Filer)
Form POS AM
03/13/2025
3:20 PM
REGENXBIO (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/12/2025
2:07 PM
JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
REGENXBIO (Subject)
Form SCHEDULE 13G/A
02/05/2025
6:49 AM
REGENXBIO (Subject)
STATE STREET CORP (Filed by)
Form SCHEDULE 13G
01/31/2025
8:54 AM
REGENXBIO (Subject)
VANGUARD GROUP INC (Filed by)
Form SCHEDULE 13G/A
01/14/2025
4:19 PM
REGENXBIO (Issuer)
Simpson Curran (Reporting)
Form 4/A
01/14/2025
6:08 AM
REGENXBIO (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2025
5:45 PM
BlackRock, Inc. (Filed by)
REGENXBIO (Subject)
Form SCHEDULE 13G
12/30/2024
3:09 PM
REGENXBIO (Subject)
Vasista Vittal (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/09/2024
4:12 PM
REGENXBIO (Filer)
Form 424B5
12/09/2024
3:45 PM
REGENXBIO (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
8:00 PM
Redmile Group, LLC (Filed by)
REGENXBIO (Subject)
Form SC 13G/A
11/06/2024
3:10 PM
REGENXBIO (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2024
12:49 PM
REGENXBIO (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/17/2024
10:42 AM
JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
REGENXBIO (Subject)
Form SC 13G/A
09/18/2024
4:03 PM
Chan Mitchell (Reporting)
REGENXBIO (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/18/2024
4:04 PM
Chan Mitchell (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
4:00 PM
REGENXBIO (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/04/2024
7:20 PM
KARABELAS ARGERIS N (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:RGNX) was last updated on 8/22/2025 by MarketBeat.com Staff
From Our Partners